Coronavirus (COVID-19) Update - We are open with your safety in mind.
Click here to learn more.
This is a 14-month, randomized, Phase 2 clinical study comparing the impact of Na-GST-1 vaccination on controlled human hookworm infection in healthy volunteers. Participants will receive 3 injections of the investigational hookworm vaccine (or placebo), followed by infection with 50 human hookworm larvae.
David Diemert, MD/Medicine